Mylan has appointed Bill Szablewski, CFA, Head of Capital Markets, in a new leadership role working closely with senior leadership. He will be serving in that same capacity for Viatris.

At Viatris, Szablewski will be responsible for building Viatris’ brand, reputation and network of relationships in global capital markets across equity and fixed income investors. Szablewski will oversee the company’s investor relations and treasury functions and will be a member the Global Finance leadership team reporting to Sanjeev Narula, the future chief financial officer of Viatris.

Mylan Executive Chairman Robert J. Coury said: “We are thrilled to welcome Bill to the team and believe that his leadership skills and vast expertise in capital markets and investor relations will be essential as we grow Viatris and develop as a company.”

Szablewski has nearly 15 years of experience in the healthcare industry. Szablewski most recently served as Assistant Treasurer, Capital Markets at Bristol Myers Squibb, where he supported the successful shareholder vote and debt financing for the Celgene acquisition.  He managed external relationships with banking counterparties, rating agencies, and fixed income investors and analysts. Prior to this role, Szablewski served as Director of Investor Relations, with responsibilities that included supporting the executive leadership team, developing and executing investor relations strategy, and global shareholder targeting campaigns.